events Archives - Page 4 of 10 - Sanford Burnham Prebys
Institute News

Sanford Burnham Prebys celebrates first graduate school Commencement ceremony

AuthorGreg Calhoun
Date

June 7, 2024

The Sanford Burnham Prebys Graduate School of Biomedical Sciences held its first-ever Commencement ceremony to celebrate nearly 20 years of educating future scientists

On Friday, May 31, 2024, the Sanford Burnham Prebys Graduate School of Biomedical Sciences hosted four graduates, their family members and friends as well as current students, faculty members and staff at the Institute’s campus in La Jolla for the school’s first-ever Commencement ceremony.

In addition to honoring the four graduates in attendance, the event also recognized the 62 other alumni who graduated from the Institute’s graduate school in the nearly 20 years since its founding in 2006.

“The graduate school is a direct extension of our commitment to training the next generation of scientists,” said David Brenner, MD, president, CEO and Donald Bren Chief Executive Chair at Sanford Burnham Prebys, during his welcoming remarks. “We focus on cultivating a collaborative culture where students are full participants. Thank you for your dedication to learning and creating new knowledge, and for your contributions to our mission of translating science to improve health.”

Brenner added, “We’re incredibly proud of you!”

Alessandra Sacco, PhD, director of, and professor in, the Development, Aging and Regeneration Program at Sanford Burnham Prebys, and dean of the Institute’s Graduate School of Biomedical Sciences, delivered the Commencement address.

“Hold onto perseverance and trust in yourself as you move forward,” said Sacco. “Never forget the sacrifices you have made, the hours in the lab and the failed experiments that have shaped you into better researchers.”

Sacco also remarked, “You are the next generation of scientists. You can make a difference by pushing on scientific boundaries while also having a positive influence on your communities.”

Alessandra Sacco, PhD, director of, and professor in, the Development, Aging and Regeneration Program at Sanford Burnham Prebys, and dean of the Institute’s Graduate School of Biomedical Sciences, delivered the Commencement address.

After concluding her remarks by wishing the graduates great success throughout their professional journeys, Sacco introduced Stephen Sakuma, PhD ’24, to speak on behalf of the Institute’s 66 alumni.

Stephen Sakuma, PhD ’24, spoke on behalf of the Institute’s
66 alumni.

“The faculty and community at Sanford Burnham Prebys have been tremendous and afforded me the most meaningful opportunities to learn and grow,” said Sakuma. “The journey has been long and, at times, arduous, but it also has been exceedingly rewarding.”

Diane Klotz, PhD, chief learning officer at Sanford Burnham Prebys, then discussed the meaning of the hoods and symbols that are used in Commencement ceremonies. She recognized the Institute’s alumni, both present and across the globe, and explained that all graduates are conferred degrees following the completion of all educational requirements and successful defense of their theses.

The Commencement ceremony, then, represents an opportunity to welcome back and celebrate with our alumni and their friends and family, and to pay tribute to alumni unable to attend who entrusted Sanford Burnham Prebys with their graduate education and preparation to enter the field of biomedical research.

Klotz invited the graduates forward and instructed faculty members to adorn them with the doctoral academic hoods signifying completion of a PhD program.

The graduates who attended the Commencement ceremony were:

  • Monica Gonzalez Ramirez, PhD ’18, who trained in the Salvesen lab and was hooded by Guy Salvesen, PhD, emeritus professor
  • James Kent, PhD ’22, who trained in the Marassi lab and was hooded by Dr. Guy Salvesen
  • Rachael McVicar, PhD ’23, who trained in the Snyder/Leibel lab and was hooded by Evan Snyder, MD, PhD, director of the Center for Stem Cells and Regenerative Medicine and professor in the Human Genetics Program
  • Stephen Sakuma, PhD ’24, who trained in the D’Angelo lab and was hooded by Maximiliano D’Angelo, PhD, associate professor in the Cancer Metabolism and Microenvironment Program

As the inaugural dean of the Institute’s graduate school, Salvesen provided the ceremony’s closing remarks. He wished the alumni well and supported Sacco’s assertion that their perseverance would be rewarded, which he reinforced with a quote from author and Arches National Park enthusiast Edward Abbey.

“May your trails be crooked, winding, lonesome, dangerous, leading to the most amazing view.”


Related Posts

Graduate School Of Biomedical Sciences

Institute News

Pancreatic cancer symposium celebrates 10th anniversary in San Diego

AuthorGreg Calhoun
Date

May 22, 2024

The 2024 PancWest Symposium brought more than 120 scientists to the Sanford Burnham Prebys campus in San Diego to discuss the latest advances in pancreatic cancer research.

More than 120 pancreatic cancer researchers from the West Coast traveled to San Diego from as far as Vancouver to attend the 2024 PancWest Symposium on May 17. The PancWest Symposium was founded in 2014 to regularly bring the scientific community studying pancreatic cancer together to discuss advances in the field and foster new collaborations.

The PancWest Symposium is held every two years in a different city to showcase expert scientists who are making important contributions to the field of pancreatic cancer research, including tumorigenesis, tumor progression and the discovery of novel therapeutic paradigms, such as immunomodulation and metabolic targeting.

The 2024 event was held on the Sanford Burnham Prebys campus in the Fishman Auditorium and was hosted by Cosimo Commisso, Ph.D., director of, and associate professor in, the Institute’s Cancer Metabolism and Microenvironment Program; and Pamela Itkin-Ansari, Ph.D., adjunct professor in the Institute’s Development, Aging and Regeneration Program.

“While pancreatic cancer accounts for only three percent of cancer cases, it has the highest mortality rate among major cancers and is the third leading cause of cancer-related death in the U.S.,” says Commisso.

PancWest Symposium poster presentations in Chairmen's Hall

The symposium’s events included a keynote address, 12 featured speakers, a poster session and a series of “power talks” providing attendees a chance to hear two-minute oral presentations from selected poster presenters.

“Unless we find ways to better diagnose and treat this disease, it is projected to become the second most deadly cancer in less than 20 years,” adds Itkin-Ansari. “That is why events such as PancWest are so important to enhance innovation and foster collaboration.”

Rosalie C. Sears, Ph.D., professor of Molecular and Medical Genetics, co-director of the Brenden-Colson Center for Pancreatic Care and Krista L. Lake Chair in Cancer Research at Oregon Health & Science University in Portland, gave the symposium’s keynote address.

Additional events at the symposium included 12 featured speakers, a poster session and a series of “power talks” providing attendees a chance to hear two-minute oral presentations from selected poster presenters.

“Being a part of PancWest has been a transformative experience,” shares Itkin-Ansari. “The exchange of groundbreaking research and innovative ideas among leading experts advanced our scientific understanding.”

“It also paved the way for new therapeutic strategies, ultimately offering hope and improved outcomes for patients battling pancreatic cancer,” adds Commisso.

More information about the symposium and featured speakers is available on the event’s webpage.

Institute News

The Conrad Prebys Foundation fellows take center stage

AuthorGreg Calhoun
Date

May 20, 2024

Following a year of hands-on training and scientific inquiry supported by a generous grant from the Conrad Prebys Foundation, a diverse group of early-career researchers recently presented their promising progress on translational research projects.

Twelve scientists-in-training at Sanford Burnham Prebys presented research updates at the Conrad Prebys Foundation Fellows Symposium on May 14, 2024, at the Institute’s Fishman Auditorium.

The presentations were the culmination of a yearlong educational program at Sanford Burnham Prebys providing early-career scientists with workshops, mentorship and research experiences focused on how to transform research discoveries into new treatments. The Conrad Prebys Foundation provided critical funding for the program as part of the foundation’s mission to increase the diversity of San Diego’s biomedical workforce.

“This truly has been a pioneering program at the Institute,” says Alessandra Sacco, PhD, director of, and professor in, the Development, Aging and Regeneration Program at Sanford Burnham Prebys; and dean of the Institute’s Graduate School of Biomedical Sciences.

The graduate students and postdoctoral fellows selected to participate in the program conducted projects at the Institute’s  Conrad Prebys Center for Chemical Genomics (Prebys Center), the nation’s leading nonprofit drug discovery center. The Prebys Center specializes in finding new medicines for diseases with a substantial unmet medical need.

Conrad Prebys Foundation fellows poster presentations

“Each participant worked with a pair of co-mentors, one in the laboratory and another in the Prebys Center,” adds Sacco. In addition to extensive mentorship, the program included educational sessions about the drug discovery process.
“This program’s multifaceted approach to training and development has been incredibly rewarding,” says Sacco. Before introducing the symposium’s first speaker, Sacco thanked Michael Jackson, PhD, senior vice president of Drug Discovery and Development at the Prebys Center and director of the Institute’s Cancer Molecular Therapeutics Program; Jessica Colomb, associate director of Administration at the Prebys Center; and all the mentors who contributed to the program’s success.

Conrad Prebys Foundation fellows poster presentations

After the conclusion of the fellows’ formal presentations, Lauren Mitchell, MS, program manager for Diversity, Equity, Inclusion and Belonging (DEIB) at Sanford Burnham Prebys, moderated a discussion for fellowship awardees regarding how this training program enriched their skillset, benefited their career development and contributed to their overall sense of belonging and community, among other topics.

The symposium ended with a poster session and reception celebrating the Conrad Prebys Foundation, participants, mentors and contributors.

“I would like to express my utmost gratitude to the Conrad Prebys Foundation for this fellowship,” says Xiuqing Wei, PhD, postdoctoral associate in the lab of Lorenzo Puri, MD, director of, and professor in, the Development, Aging and Regeneration Program at Sanford Burnham Prebys.

Wei adds, “It was a wonderful experience working with my co-mentors on an amazing translational research project.” Wei focused on methods for targeting the abnormal regulation of a key proinflammatory cytokine which is associated with muscle waste under the conditions of nerve injuries and cancer.

The Conrad Prebys Foundation fellows who presented at the symposium were:

Postdoctoral Fellows

  • Merve Demir
    Zhao Lab, Ed Sergienko co-mentor
    “Structural studies of MtCK and GCDH enzyme drug targets”
  • Alicia Llorente Lope
    Emerling Lab, Ian Pass co-mentor
    “Exploring PI5P4Kγ as a novel molecular vulnerability of therapy-resistant breast cancer” 
  • Van Giau Vo
    Huang Lab, TC Chung co-mentor
    “Identifying enhancers of SNX27 to promote neuroprotective pathways in Alzheimer’s disease and Down Syndrome”
  • Xiuqing Wei
    Puri Lab, Anne Bang co-mentor
    “Selective targeting of a pathogenetic IL6-STAT3 feedforward loop activated during denervation and cancer cachexia”

Predoctoral Fellows

  • Michael Alexander Alcaraz
    Adams Lab, Steven Olson co-mentor
    “Activating the NAMPT-NAD+ axis in senescence to target age-associated disease”
  •   Shea Grenier Davis
    Commisso Lab, Steven Olson co-mentor
    “Examining PIKfyve as a potential therapeutic target in pancreatic cancer” 
  • Aditi Pedgaonkar
    Deshpande Lab, Ed Sergienko co-mentor
    “SGF29 as a novel therapeutic target in AML” 
  • Patrick Hagan
    Cosford Lab, Ian Pass co-mentor
    “Discovery and development of novel ATG13 degrading compounds that inhibit autophagy and treat non-small-cell lung cancer” 
  • Texia Loh
    Wang Lab, Ed Sergienko co-mentor
    “Investigating the role of HELLS in mediating resistance to PARP Inhibition in small-cell lung cancer” 
  • Michaela Lynott
    Colas Lab, TC Chung co-mentor
    “Identification of small molecules inhibiting ATF7IP-SETDB1 interacting complex to improve cardiac reprogramming efficiency” 
  • Tatiana Moreno
    Kumsta Lab, Anne Bang co-mentor
    “Identifying TFEB/HLH-30 regulators to modulate autophagy in age-related diseases” 
  • Utkarsha Paithane
    Bagchi Lab, TC Chung co-mentor
    “Identification of small-molecule enhancers of Honeybadger, a novel RAS/MAPK inhibitor”
Institute News

Showcasing stellar scientists-in-training: The Rising Stars Symposium at Sanford Burnham Prebys

AuthorGreg Calhoun
Date

May 7, 2024

The annual event brought 12 doctoral-degree candidates and postdoctoral fellows to the Institute to help nurture diversity in research and feature Rising Stars poised to move science forward.

Sanford Burnham Prebys recently hosted its third annual Rising Stars Symposium, a research meeting and networking opportunity for 12 postdoctoral candidates.

“If I could do another postdoctoral fellowship, I would do it here,” said David Brenner, MD, president, CEO and Donald Bren Chief Executive Chair at Sanford Burnham Prebys, during his opening remarks. “I hope you feel very welcome here as part of the family.”

Following Brenner’s introductory comments, Ani Deshpande, PhD, associate professor in the Cancer Genome and Epigenetics Program at Sanford Burnham Prebys and associate director of Diversity, Equity and Inclusion in the Institute’s NCI-designated Cancer Center, introduced the symposium’s keynote speaker, Thomas Martínez, PhD, assistant professor of Biological Chemistry and Pharmaceutical Sciences at the University of California, Irvine.

“I have read all the participants’ biographies, and it is clear you all truly are rising stars,” said Martínez. “Every journey in science is unique, but if you find great mentors, adopt an attitude of service and seek to engage with your community, that will carry you a long way.”

The 12 Rising Stars were then invited to give presentations on research they conducted during their graduate school training.

“I was really excited to share my research at Sanford Burnham Prebys,” says Rebecca Mello, a 2024 Rising Star and graduate student at the Scripps Research Skaggs Graduate School of Chemical and Biological Sciences. “It was an amazing opportunity to participate in such a prestigious event.”

Thomas Martinez, PhD, headshot

Keynote speaker, Thomas Martínez, PhD, assistant professor of Biological Chemistry and Pharmaceutical Sciences at the University of California, Irvine

Rebecca Mello headshot

Rebecca Mello, 2024 Rising Star and graduate student

In addition to the full-day symposium, the Rising Stars took tours of the Institute, learned about its core facilities and shared research resources, networked with Institute scientists, and gained a better understanding of postdoctoral opportunities at Sanford Burnham Prebys.

“It was really lovely to meet many members of the faculty and staff,” adds Mello. “It seems like a really welcoming community and a well-equipped research institution.”

“When you compare the symposium to a normal recruiting visit where you might go to one lab and some core facilities, this event allows you to have many more interactions and leaves you with a much more complete understanding of the Institute and its collaborative culture,” says Evelyn Sanchez Hernandez, PhD, a 2023 Rising Star who joined Sanford Burnham Prebys as a postdoctoral associate in the Bradley lab and the Cancer Metabolism and Microenvironment Program. Hernandez moderated a session at this year’s event.

The planners are grateful for everyone who contributes to this Institute-wide effort, including workshop facilitators, panelists, the Communications team, the Research Administrative Services team and many volunteers.

“It made me proud to work here seeing the tremendous partnerships in action that make this symposium possible,” says Lauren Mitchell, MS, program manager for DEIB at Sanford Burnham Prebys. “I think we were successful in shaking up the standard recruiting process and opening the eyes of both the Stars and attendees to new potential opportunities.”

Hernandez says, “This event is really important because it helps promote and foster more diversity in the scientific community, which is something I want to contribute to and help make happen throughout my career.”

Institute News

At a symposium on rare diseases, smiles were in abundance

AuthorScott LaFee
Date

March 28, 2024

Since 2010, we have organized an annual scientific and family conference at Sanford Burnham Prebys that covers multiple rare diseases.

In alternate years, this meeting has focused on Congenital Disorders of Glycosylation (CDG).

Our 2024 meeting this month was a cause for celebration. Partnering with the family support and information group, CDG CARE, the Sanford Children’s Health Research Center and sponsors invited scientists, families and physicians to share their stories – some technical, some heart-breaking, some updates of ongoing therapies and some describing new developments.

Five years ago, there were no therapies; now seven are moving into patients. Celebration indeed.

Our keynote speaker, Joni Rutter, PhD, director of the National Center for Advancing Translational Sciences, part of the National Institutes of Health, commented on our event:  “Meetings that engage clinicians, scientists, advocates and families equally should be the standard. (Our) approach is a model of collaboration and impact.”

In this CDG CARE video of this month’s gathering, you can see the joy, optimism and hope that inspires and helps carry us all. Thanks to everyone for their support. It makes those smiles real.

Institute News

Melanoma’s mysteries revealed at Sanford Burnham Prebys

AuthorGreg Calhoun
Date

March 26, 2024

Cancer Center open house welcomes San Diego community to learn the latest about melanoma research

The Institute’s NCI-designated Cancer Center hosted the open house on Wednesday, March 20. It provided an opportunity for community members to meet scientists who seek to better understand melanoma and use this knowledge to improve treatment and prevention.

The event was sponsored by the center’s Community Advisory Board, an eight-member committee that focuses on advocacy, education and community engagement, as well as providing Cancer Center leaders and members with the perspectives of patients, survivors and their loved ones.

Open house participants could select from a variety of activities. Two labs provided brief poster presentations.

Ze’ev Ronai, PhD, director of the Sanford Burnham Prebys Cancer Center and the Jeanne and Gary Herberger Leadership Chair in Cancer Research, and his team discussed several areas of research, including the dissection of microbiota commensals which support the immune system’s fight against melanoma, the studies undertaken to understand melanoma addiction to the metabolic enzyme GCDH, and the development of new drugs to target the molecular machine that translates genetic instructions into proteins, which are known to be hyperactive in cancer cells.

Linda Bradley, PhD, professor in the Cancer Metabolism and Microenvironment Program at Sanford Burnham Prebys, and her group detailed their work on improving the immune system response to viral infections and cancer, including a new potential immune checkpoint therapy and efforts to rejuvenate overstressed immune cells to enhance the effectiveness of immunotherapy.

Attendees also could take tours of two different research facilities. Many participants enjoyed an insider’s view into the field of cryo-electron microscopy (cryo-EM), a technology that garnered three key innovators the 2017 Nobel Prize in Chemistry. The Cryo-EM core facility enables scientists to create 3D images of the cell and all its constituent parts that are accurate to the tiniest detail as it is able to capture individual atoms. Images taken using cryo-EM can be organized sequentially to develop films that show in real time how the cell’s many actors interact, helping scientists map interactions between drugs identified at Sanford Burnham Prebys and their target proteins, thereby advancing novel modalities for the treatment of melanoma and other cancers.

The second tour brought community members to the Conrad Prebys Center for Chemical Genomics. The Prebys Center is the Institute’s comprehensive center for drug discovery and chemical biology. Visitors were able to see the center’s state-of-the-art robots that enable researchers to quickly test the potential effectiveness of hundreds of thousands of compounds to find new prospective treatments. Many scientists at Sanford Burnham Prebys partner with the Prebys Center to conduct drug discovery searches based on new research findings, including those studying melanoma and other cancers.

Many of the visitors had the opportunity to visit a melanoma research laboratory to learn about research projects in the Ronai lab and view melanoma cells as seen under the microscope.

Open House guests conversing in Chairmen's Hall

Following the tours, Ronai shared an overview of the Cancer Center and highlighted recent accomplishments. Attendees interacted with Gregory Daniels, MD, PhD, a medical oncologist and melanoma expert from University of California San Diego and Steven Silverstein, a melanoma survivor, former president of the Melanoma Research Foundation and a melanoma research advocate. The open house concluded with an opportunity for guests to speak with cancer scientists and featured speakers during the evening reception.

“We were honored to provide our valued guests with the opportunity to learn about the research conducted at our Cancer Center, including ongoing melanoma research,” says Ronai. “Our open houses, which focus on different unmet needs in cancer, allow us to welcome and engage with the San Diego community, to share our findings and be inspired by patients and their loved ones.”

Institute News

Seminar Series: extrachromosomal DNA and the metabolic circuits of cancer immune suppression

AuthorScott LaFee
Date

March 25, 2024

The ongoing Sanford Burnham Prebys seminar series will feature a pair of speakers on March 27, from noon to 1p.m., in the Fishman Auditorium. They will be presenting on two topics: extrachromosomal DNA and the tumor microenvironment.

First, Owen Chapman, PhD, a postdoctoral research scientist in the lab of Lukas Chavez, PhD, will discuss clinical and genomic features of circular extrachromosomal DNA (ecDNA) in medulloblastomas, a type of brain tumor.

EcDNA is DNA found off chromosomes, either inside or outside the nucleus of a cell. In a study published last year, Chavez (senior author), Chapman (first author) and colleagues reported that patients with medulloblastomas containing ecDNA are twice as likely to relapse after treatment and three times as likely to die within five years of diagnosis.

The second presentation will be by Kevin Tharp, PhD assistant professor in the Cancer Metabolism and Microenvironment Program. Tharp, who joined Sanford Burnham Prebys in December 2023, studies how tumors manipulate their mitochondria to improve survivability and how those cellular mechanics can be leveraged to create more effective therapies.

Institute News

Sanford Burnham Prebys Cancer Center seminar on March 25

AuthorGreg Calhoun
Date

March 25, 2024

The Sanford Burnham Prebys Cancer Center is hosting a special seminar on Monday, March 25, from noon to 1 p.m. at the Fishman Auditorium in Building 4 on the Sanford Burnham Prebys campus, 10901 North Torrey Pines Road, La Jolla, Calif., 92037.

The seminar’s featured speaker is Eric S. Fischer, PhD, professor of biological chemistry and molecular pharmacology at Harvard University. Fischer will discuss the topic, “Molecular Mechanisms of Ubiquitin Ligases– From Structure to Therapies.” More details on the seminar subject are available in the abstract below.

Abstract:  Small molecules that induce protein degradation through ligase-mediated ubiquitination have shown considerable promise as a new pharmacological modality. Thalidomide and related immunomodulatory drugs provided the clinical proof of concept while significant progress has recently been made towards chemically induced targeted protein degradation using heterobifunctional small molecule ligands. Fischer will present recent work to develop a better understanding of the molecular principles that govern neo-substrate recruitment and its application to the development of small molecule degraders.

For more information on the seminar, please contact Valerie Alanis at valanis@sbpdiscovery.org

Pizza and refreshments will be served.

Institute News

Sharing science and stories at Rare Disease Day Symposium

AuthorGreg Calhoun
Date

March 7, 2024

The Sanford Burnham Prebys Rare Disease Day Symposium brought patients, families, physicians, scientists, industry experts and advocates together with a focus on congenital disorders of glycosylation.

Sanford Burnham Prebys, in partnership with CDG CARE and the Sanford Children’s Health Research Center, hosted a Rare Disease Day Symposium in San Diego from March 1-3, 2024. The goal of the event was to share the latest scientific developments from researchers studying congenital disorders of glycosylation (CDG), and to foster new perspectives, ideas and collaborations to accelerate the creation and implementation of better therapies and treatment plans for those living with CDG.

CDG is an umbrella term for more than 190 disorders caused by mutations that impair glycosylation; the complex process by which cells build long sugar chains that attach to proteins called glycoproteins. CDG affects fewer than 2,000 children worldwide. When glycosylation is impaired, the sugar molecules on many of the body’s proteins are absent or incomplete, leading to serious, often fatal, malfunctions in various organ systems throughout the body.

Since 2010, Hudson Freeze, PhD, the William W. Ruch Distinguished Endowed Chair, professor and director of the Human Genetics Program, and director of the Sanford Children’s Health Research Center at Sanford Burnham Prebys, has organized an annual Rare Disease Symposium, where scientists, doctors and families gather from around the world to discuss the latest research and meet other families coping with rare diseases.

“At Sanford Burnham Prebys, we’re committed to rare disease research,” says David Brenner, MD, president, CEO and Donald Bren Chief Executive Chair at Sanford Burnham Prebys, during his welcoming remarks. “We believe we can make a unique contribution to society with this work, and in so doing make the world a better place.”

Rare Disease Day Welcome speakers, Malin Burnham, Hudson Freeze, David Brenner

Brenner noted that Rare Research Day marked a time for academic medical centers across the US to celebrate the synergy between patients, families, physicians and scientists that is needed to advance research on all rare diseases, including CDG.

This was reflected throughout the symposium’s schedule and in the tenor of individual presentations. Patients and families were invited to give talks throughout the weekend to discuss the perspective of living with CDG or caring for a family member with CDG. The physicians and scientists who spoke consistently credited the patients and families for all they do to help raise funds and participate in research, including clinical trials that can add more appointments to already challenging calendars and routines.

The family reception on Friday, March 1, concluded the first day of the symposium with a more informal opportunity for patients, families, doctors and researchers to connect and socialize.

“This is the largest meeting we’ve ever had,” notes Freeze. “This gathering is an important part of nurturing the CDG research ecosystem by bringing experts together while also knitting us closer together with the people who really matter – the families.”

The symposium’s many sessions over three days included:

  • Friday, March 1
    • Scientific meeting
      • Introduction and welcome from Sanford Burnham Prebys president and CEO, David Brenner; Malin Burnham and Debra Turner, philanthropists and honorary trustees; and Congressional Representative Scott Peters from California’s 52nd Congressional District
      • Discussion of perspectives, challenges and triumphs led by parents, patients and advocates
      • Sessions on new therapies in development, the potential use of biotin as a treatment for many CDG patients, neurological disease, and gene therapy approaches, among others 
    • Poster session
    • Family reception
  • Saturday, March 2
    • Scientific meeting
      • Keynote address on “Accelerating Treatment and Cures for Rare Diseases” from Joni Rutter, PhD, director of the National Center for Advancing Translational Sciences in the National Institutes of Health
      • Additional conversation about the experiences of parents and advocates
      • Sessions on clinical trial updates; especially strong were drug repurposing efforts leading to new and unexpected potential treatments
    • Doctor-is-in-session
      • Brought together medical researchers, clinicians, advocates, patients and their families for an afternoon of hands-on collaboration in small groups
      • Prior “Doctor-is-in-session” events have led to profound experiences and unlikely partnerships
    • Evening reception
  • Sunday, March 3
    • CDG CARE Scientific and Family Conference
      • CDG clinical care and management sessions included neurophysiology and epilepsy, growth charts and hormonal abnormalities, puberty and bone health
      • CDG research sessions included genetics 101, CDG updates, organoids as disease models and clinical trials as a partnership between physicians and patients, among others
      • CDG resource exchange sessions included educational planning and advocacy, speech and technology, therapy interventions, special needs planning and behavioral health and family planning
Institute News

Time to talk about aging research

AuthorGreg Calhoun
Date

February 29, 2024

Hundreds of scientists gather in San Diego and virtually to share knowledge on the science of aging

For scientists in San Diego and across the United States, March 6-7, 2024, is an important time to talk about developments in aging research. To kick off two scientific meetings on the subject, the NIH-funded San Diego Nathan Shock Center, a collaboration among the Salk Institute for Biological Studies, Sanford Burnham Prebys and the University of California San Diego, will host its 2024 symposium focused on the center’s primary research area, “The Heterogeneity of Aging,” on Wednesday, March 6 at the Salk Institute for Biological Studies in the Conrad T. Prebys Auditorium in La Jolla.

Just as people and organisms age at different rates, scientists have demonstrated that tissues also age at their own speeds – even some cells within tissues age at a unique pace. This phenomenon, known as heterogeneity of aging, is of great interest to researchers as it may hold clues for how to develop interventions that enable people to lead healthier lives as they age. to discuss this topic.

Caroline Kumsta, PhD, assistant professor in the Development, Aging and Regeneration Program at Sanford Burnham Prebys and associate dean of student affairs of the Institute’s Graduate School of Biomedical Sciences, will speak at the 2024 symposium about heterogeneity of aging within the process cells use to recycle or dispose of damaged DNA and other waste products. Kumsta recently coauthored a manuscript in Nature Aging that found new functions for genes involved in this waste management process, known as autophagy. Gaining a better understanding of autophagy is important as scientists have demonstrated that autophagy genes are responsible for prolonged life span in a variety of long-lived organisms. Kumsta received a pilot award from the San Diego Nathan Shock Center in 2022 to support her research on the subject.

“We’re excited to once again offer the La Jolla Aging Meeting on the next day, as we have found that many people like to attend both, and that both meetings help each other,” says Alessandra Sacco, PhD, cohost of both events, director of and professor in the Development, Aging and Regeneration Program at Sanford Burnham Prebys, and dean of the Institute’s Graduate School of Biomedical Sciences.

The 7th annual La Jolla Aging Meeting will be held on Thursday, March 7, also in Salk’s Conrad T. Prebys Auditorium. The meeting was organized by Sacco and Peter Adams, PhD, director of and professor in the Cancer Genome and Epigenetics Program at Sanford Burnham Prebys, and by Jan Karlseder, PhD, Donald and Darlene Shiley Chair, senior vice president and chief science officer at the Salk Institute. The event features mostly short talks from San Diego-based postdoctoral fellows and students researching the biology of aging. The meeting’s goal is to enable participants to meet other researchers and start new collaborations.

“The La Jolla Aging Meeting has more of a focus on early career development, so the events complement each other very well,” adds Sacco.

Three members of Sanford Burnham Prebys will be presenting at the La Jolla Aging Meeting, including Xiao Tian, PhD, who recently joined the Institute as an assistant professor in the Degenerative Diseases Program. Tian focuses on epigenomic changes and deterioration that influence age-related diseases by studying the remarkable traits of naked mole rats: They rarely get cancer. They are resistant to some types of pain. They can survive up to 18 minutes without oxygen. And compared to their rodent peers, naked mole rats age very slowly. Tian’s goal is to unravel the molecular basis of aging and develop strategies to promote a healthier, more vital lifespan.

Last year, more than 400 academics, students and trainees at every career stage gathered in person and virtually from 20 states and several countries to participate in the San Diego Nathan Shock Center “The Heterogeneity of Aging” Symposium and the La Jolla Aging Meeting.

About the San Diego Nathan Shock Center
The San Diego Nathan Shock Center (SD-NSC), led by Gerald Shadel, PhD, Audrey Geisel Chair in Biomedical Science and professor in the Molecular and Cell Biology Laboratory at the Salk Institute, was established in the fall of 2020 with the overall goal of understanding the heterogeneity of aging in order to allow development of personalized interventions to increase the number of years of healthy life. To this end, the center provides three novel scientific Research Resource Cores to develop new human cell models of aging and enable the integrated analysis of molecular, cellular and tissue heterogeneity. The SD-NSC also supports and advocates basic biology of aging research in general through the development, training and mentoring activities of a Research Development Core and robust outreach efforts. All of these activities are accomplished via a consortium of three premier research institutions on the La Jolla Research Mesa: the Salk Institute for Biological Studies, Sanford Burnham Prebys and the University of California San Diego.

Alessandra Sacco serves as director of the SD-NSC Research Development Core and Peter Adams serves as codirector of the SD-NSC Heterogeneity of Aging Core.